Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation.
Yamasaki S, Yoshimoto G, Kohno K, Henzan H, Aoki T, Tanimoto K, Sugio Y, Muta T, Kamimura T, Ohno Y, Ogawa R, Eto T, Nagafuji K, Miyamoto T, Akashi K, Iwasaki H; Fukuoka Blood and Marrow Transplantation Group.
Yamasaki S, et al. Among authors: aoki t.
Int J Hematol. 2019 Jan;109(1):98-106. doi: 10.1007/s12185-018-2538-8. Epub 2018 Sep 24.
Int J Hematol. 2019.
PMID: 30251131